Chronic, recurrent Lymphocytic Leukemia Active Not Recruiting Phase 2 Trials for Venetoclax (DB11581)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02756897Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic LeukemiaTreatment
NCT03045328Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLLTreatment